Related Experiment Video
Updated: Aug 10, 2026
11:55
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Allogeneic hematopoietic cell transplantation for multiple myeloma
W I Bensinger1, D Maloney, R Storb
1University of Washington, Seattle, WA, USA.
Seminars in Hematology
|August 7, 2001
Summary
Allogeneic stem cell transplants offer long-term disease-free survival for multiple myeloma (MM) patients, potentially due to a graft-versus-myeloma effect. Reducing transplant complications is key to wider use of this curative therapy.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Multiple myeloma (MM) is a malignancy historically resistant to therapies.
- Allogeneic hematopoietic stem cell transplantation (allo-HSCT) shows promise for long-term MM remission.
Purpose of the Study:
- To evaluate the long-term efficacy of allo-HSCT in multiple myeloma.
- To explore the mechanisms behind sustained remission after allo-HSCT.
Main Methods:
- Analysis of long-term follow-up data for MM patients post-allo-HSCT.
- Comparison of survival outcomes between allogeneic and autologous stem cell transplants.
- Investigation of the graft-versus-myeloma (GVM) effect.
Main Results:
- Some MM patients achieve 5-13 years of disease-free survival after allo-HSCT.
- Long-term progression-free survival appears unique to allograft recipients, suggesting a GVM effect.
- Survival rates at 3-5 years are similar for both allogeneic and autologous transplants.
Conclusions:
- Allo-HSCT can lead to long-term disease control in multiple myeloma.
- The graft-versus-myeloma effect is crucial for sustained remission.
- Reducing transplant-related mortality and complications is essential for broader clinical application.
More Related Videos
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...